Polio (poliomyelitis)

Overview

Poliomyelitis is the neurologic disease caused when poliovirus spreads beyond the gastrointestinal tract and damages motor neurons in the spinal cord or brainstem. Most infected people never develop neurologic disease, but because asymptomatic people can shed virus, transmission can occur before a paralytic case is recognized. ^{[1] [2]}

Poliovirus enters through the mouth, replicates in the oropharynx and intestine and is shed in stool for weeks. In a small fraction of infections it enters the central nervous system and injures anterior horn motor neurons, producing asymmetric flaccid weakness without the sensory loss typical of many peripheral nerve disorders. ^{[1] [2]}

Global vaccination has eliminated endemic wild poliovirus from most countries, but wild transmission continues in limited areas and outbreaks of circulating vaccine-derived poliovirus can occur where immunization coverage is low. International travel therefore remains relevant to case recognition and vaccination planning. ^{[1] [2] [3]}

Symptoms and warning signs

Most infections are asymptomatic. About one in four infected people may develop a mild flu-like syndrome with fever, sore throat, fatigue, nausea, headache or abdominal symptoms. Nonparalytic meningitis causes neck or back stiffness and pain. Paralytic disease produces acute asymmetric weakness, decreased reflexes and sometimes breathing or swallowing impairment. ^{[1] [2]}

New acute flaccid weakness or paralysis—particularly in an unvaccinated or incompletely vaccinated person or after travel to an area with poliovirus circulation—requires urgent medical and public-health evaluation. Breathing difficulty, swallowing weakness or rapidly progressive paralysis requires emergency care. ^{[1] [2]}

Diagnosis

Clinical suspicion is based on acute flaccid paralysis or compatible meningitis plus vaccination and travel/exposure history. Because many disorders can cause AFP, laboratory confirmation is essential and clinicians should involve public-health authorities immediately rather than order routine testing in isolation. ^{[1] [2]}

Stool specimens are particularly important because poliovirus is shed in the gastrointestinal tract; respiratory specimens can also be tested. Viral isolation and molecular typing determine whether poliovirus is present and whether it is wild, vaccine-derived or vaccine-like. Cerebrospinal fluid is often obtained to evaluate AFP, but a negative CSF test does not rule out polio. ^{[1] [2] [3]}

Guillain–Barré syndrome, enterovirus D68-associated acute flaccid myelitis, transverse myelitis, botulism, spinal cord compression and other infectious or inflammatory neurologic disorders can mimic paralytic polio. Distribution of weakness, reflexes, sensory findings, imaging and laboratory testing help distinguish them. ^{[2] [3]}

Causes, risk factors and clinical context

The principal risk is lack of immunity. Unvaccinated or incompletely vaccinated people are susceptible, and risk rises with travel to or residence in areas where wild or vaccine-derived poliovirus circulates. Crowding and poor sanitation facilitate fecal–oral transmission. ^{[1] [2]}

Minor illness usually resolves within days. Paralytic weakness can stabilize after the acute phase but may leave permanent deficits. Decades later, some survivors of paralytic polio develop post-polio syndrome with new weakness, fatigue and muscle or joint pain that is not caused by renewed viral infection. ^{[1] [2] [3]}

Complications and why the diagnosis matters

Permanent limb weakness, deformity, respiratory failure, swallowing dysfunction and immobility-related complications can follow paralytic disease. Bulbar and respiratory muscle involvement carries the highest acute mortality risk. ^{[1] [2]}

Most infected people recover because they never develop neurologic disease. In paralytic polio, recovery varies by extent of motor-neuron injury; some strength may return over months, while destroyed motor neurons do not regenerate and residual disability can be lifelong. ^{[1] [2] [3]}

Treatment and management

There is no antiviral treatment that eradicates poliovirus. Care is supportive: pain and fever management, prevention of respiratory and immobility complications, ventilation when respiratory muscles fail, and early rehabilitation to preserve function and prevent contractures. ^{[1] [2]}

Physical and occupational therapy are individualized. During acute weakness, overly aggressive exercise can worsen pain and fatigue; later rehabilitation focuses on efficient movement, orthoses and adaptive equipment. Post-polio syndrome management emphasizes pacing, energy conservation and treatment of pain or sleep-disordered breathing when present. ^{[1] [2] [3]}

Do not delay public-health notification while waiting for a routine neurologic work-up. Patients with suspected poliovirus infection require infection-control measures and specialized testing because silent transmission may already be occurring in close contacts or the community. ^{[1] [2]}

Follow-up, recovery and prevention

Survivors with weakness need long-term rehabilitation and periodic assessment of mobility, respiratory function, swallowing and musculoskeletal strain. New weakness many years later should be evaluated rather than assumed to be post-polio syndrome, because other neurologic and orthopedic causes are common with aging. ^{[1] [2]}

Vaccination is the central preventive measure. Routine childhood immunization and catch-up vaccination for unvaccinated adults reduce individual risk, while high population coverage prevents community circulation. Travelers may need accelerated or booster recommendations depending on destination and public-health guidance. ^{[1] [2] [3]}

Special situations and care pathway

Post-polio syndrome is not contagious and does not indicate renewed poliovirus replication. People who had paralytic disease can develop new fatigue, pain or slowly progressive weakness 15–40 years later; management differs completely from acute infection. ^{[1] [2] [3]}

For suspected acute polio, the pathway is emergency neurologic assessment, respiratory monitoring, immediate public-health notification, stool/respiratory sampling, evaluation for alternative AFP causes and supportive rehabilitation. Vaccination and contact response proceed in parallel. ^{[1] [2]}

When to seek urgent medical care

Emergency care is required for new rapid flaccid weakness, difficulty breathing or swallowing, or inability to walk. Clinicians should urgently report suspected poliomyelitis to the appropriate public-health authority. ^{[1] [2]}

Sources

1. CDC — Clinical Overview of Poliomyelitis
2. WHO — Poliomyelitis fact sheet
3. CDC — Polio Vaccination

This article is based on trusted medical sources and is awaiting clinician review. It is not a substitute for personalized medical advice.